The binding of GnRH to its receptor results in the synthesis and secretion of the gonadotropins as well as stimulation of the gene encoding its own receptor. Thus, the interaction between GnRH and GnRHR represents a central point for regulation of reproductive function. Glucocorticoids can alter reproduction by reducing GnRH responsiveness of gonadotropes within the anterior pituitary gland, potentially via transcriptional regulation of the GnRHR gene. Consistent with this, transcription of the murine GnRHR gene is stimulated by glucocorticoids. To determine the effect of glucocorticoids on porcine GnRHR gene expression, we isolated approximately 5000 bp of 5' flanking sequence for the porcine GnRHR gene and produced reporter constructs containing the GnRHR promoter fused to the cDNA encoding luciferase (-5000LUC). The gonadotrope-derived αT3-1 cell line was transiently transfected with -5000LUC for 12 h and treated with increasing concentrations of the glucocorticoid agonist, dexamethasone (1, 10, 100 and 1,000 nM) for an additional 12 h prior to harvest. A dose-dependent increase in luciferase activity was observed with maximal induction noted at 100 nM dexamethasone (2-fold over untreated controls; P < 0.05). The dexamethasone induction of the -5000 promoter was blocked by the glucocorticoid antagonist, mifepristone (100 pM). • Transient transfection of reporter constructs containing the fulllength porcine GnRHR promoter into gonadotrope-derived αT3-1 cells resulted in a dose-dependent increase in luciferase activity following treatment with increasing concentrations of the glucocorticoid agonist, dexamethasone. Optimal promoter activity occurred after treatment with 100 nM dexamethasone (Fig. 1 ).
• Transient transfection of reporter constructs containing the fulllength porcine GnRHR promoter into gonadotrope-derived αT3-1 cells resulted in a dose-dependent increase in luciferase activity following treatment with increasing concentrations of the glucocorticoid agonist, dexamethasone. Optimal promoter activity occurred after treatment with 100 nM dexamethasone (Fig. 1 ).
• Specificity of this response was confirmed by treatment with increasing amounts of the glucocorticoid antagonist, mifepristone. Promoter activity was reduced to basal levels following treatment with 100 pM mifepristone (Fig. 1 ).
• Sequential 5' deletions of -5000pGL3 demonstrated that approximately 320 bp of porcine GnRHR promoter are required for glucocorticoid responsiveness (Fig. 2 ).
• Protein kinase A and C inhibitors did not reduce glucocorticoidstimulated promoter activity, indicating that other signaling pathways are involved (Fig. 3 ).
• Sequence analysis of the -320/-270 bp region within the porcine GnRHR gene promoter revealed an SF-1 and two putative GR binding sites as well as AP-1 and GATA-1 elements.
• EMSA with probes spanning the 50 bp region between 270 and 320 bp of 5' flanking region indicated that one of the probes, representing -307/-287 bp of proximal promoter, revealed increased binding to nuclear extracts from αT3-1 cells treated with dexamethasone compared to vehicle (Fig. 4) .
Results

Future Aims
• • Vectors were constructed containing portions of the full-length porcine GnRHR promoter fused to the cDNA encoding luciferase.
• Transient transfections were performed in gonadotrope-derived αT3-1 cells using a liposome-mediated protocol (Fugene6, Roche Molecular). The reporter vector (0.9 µg) was cotransfected with a control vector, pSV-β-galactosidase (0.1 µg).
• Following 12 h of transfection, cells were treated with dexamethasone, vehicle (70% ethanol), or the appropriate inhibitor for an additional 12 h prior to harvest.
• Three transfections were completed in triplicate using DNA from three different plasmid preparations.
• Luciferase (Promega) and β-galactosidase (Tropix) assays were performed.
• Luciferase values were divided by β-galactosidase activity to normalize for transfection efficiency and means were expressed as fold changes over untreated control.
• Means for adjusted luciferase activity were compared using either Dunnett's two-tailed t-test or Tukey's studentized range test.
• EMSAs were performed using four 32 P-labeled oligonucleotides spanning the -320/-270 bp region of GnRHR promoter and crude nuclear extracts obtained from αT3-1 cells treated with 100 nM dexamethasone or vehicle. 
